
Bioorganic and Medicinal Chemistry Letters p. 2773 - 2778 (1999)
Update date:2022-08-02
Topics:
Chambers
Marfat
Antognoli
Cheng
Damon
Kuperman
Liston
Mebus
Pillar
Shirley
Watson
CP-199,330 (3) and CP-199,331 (4) are cysLT1 receptor antagonists that are equipotent to marketed cysLT1 receptor antagonists zafirlukast and pranlukast, show good pharmacokinetics in rats and monkeys, and are devoid of liver toxicity in monkeys as seen in CP-85,958 (1).
View MoreLiaoyang hengye Chemical Co., Ltd.
Contact:86-419-5850866
Address:North Old Xiaoxiao Road,Yantai District, Dengta, Liaoyang, Liaoning, China
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
A.M FOOD CHEMICAL CO., LIMITED
Contact:86-531-87100375
Address:20Floor,Bblock,1Building,pharma-valley,Jinan,China
Shanghai Korey Pharm Co.,Ltd.(expird)
Contact:021-61840961 021-61840962
Address:No.157,Zhuguang Rd, Qingpu, Shanghai, China
Yurui(Shanghai)Chemical Co.,Ltd
Contact:0086 21-50456736
Address:No.3188 Xiupu Road,Shanghai
Doi:10.1039/jr9410000547
(1941)Doi:10.1002/jlcr.3073
(2013)Doi:10.1039/c3tc32388a
(2014)Doi:10.1016/j.tetlet.2014.02.024
(2014)Doi:10.1134/S1070363214020170
()Doi:10.1002/cctc.201300640
(2014)